APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adjuvants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Adjuvants Industry Growth and Trends Forecast to 2032

26 December 2025103 pages

Choose your research edition.

Industry ResearchAdjuvants Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Adjuvants Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adjuvants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Adjuvants Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adjuvants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adjuvants include GSK, Croda, CSL Limited, Phibro Animal Health, SDA BIO, SEPPIC, SPI Pharma, Vertellus and Huanuotai Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adjuvants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adjuvants market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adjuvants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adjuvants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Adjuvants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adjuvants Market by Company

GSK

Croda

CSL Limited

Phibro Animal Health

SDA BIO

SEPPIC

SPI Pharma

Vertellus

Huanuotai Biological

Rico Bio

Sanofi

Escon

Zhifei Biological

Adjuvants Segment by Type

Emulsion Adjuvants

Mineral Adjuvants

Others

Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Emulsion Adjuvants Table 2. Major Company of Mineral Adjuvants Table 3. Major Company of Others Table 4. Global Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Adjuvants Sales by Type (2021-2026) & (Tons) Table 6. Global Adjuvants Sales Market Share in Volume by Type (2021-2026) Table 7. Global Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 8. Global Adjuvants Sales Market Share in Value by Type (2021-2026) Table 9. Global Adjuvants Price by Type (2021-2026) & (US$/Kg) Table 10. Global Adjuvants Sales by Type (2027-2032) & (Tons) Table 11. Global Adjuvants Sales Market Share in Volume by Type (2027-2032) Table 12. Global Adjuvants Sales by Type (2027-2032) & (US$ Million) Table 13. Global Adjuvants Sales Market Share in Value by Type (2027-2032) Table 14. Global Adjuvants Price by Type (2027-2032) & (US$/Kg) Table 15. North America Adjuvants Sales by Type (2021-2026) & (Tons) Table 16. North America Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Adjuvants Sales by Type (2021-2026) & (Tons) Table 18. Europe Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Adjuvants Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Adjuvants Sales by Type (2021-2026) & (Tons) Table 22. Latin America Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Adjuvants Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 25. Adjuvants Industry Trends Table 26. Adjuvants Industry Drivers Table 27. Adjuvants Industry Opportunities and Challenges Table 28. Adjuvants Industry Restraints Table 29. Global Adjuvants Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Adjuvants Revenue Market Share by Company (2021-2026) Table 31. Global Adjuvants Sales by Company (2021-2026) & (Tons) Table 32. Global Adjuvants Sales Share by Company (2021-2026) Table 33. Global Adjuvants Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Adjuvants Major Company Production Sites and Headquarters Table 36. Global Adjuvants Company, Product Type & Application Table 37. Global Adjuvants Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Adjuvants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Adjuvants Sales by Region (2021-2026) & (Tons) Table 42. Global Adjuvants Sales Market Share in Volume by Region (2021-2026) Table 43. Global Adjuvants Sales by Region (2021-2026) & (US$ Million) Table 44. Global Adjuvants Sales Market Share in Value by Region (2021-2026) Table 45. Global Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Adjuvants Sales by Region (2027-2032) & (Tons) Table 47. Global Adjuvants Sales Market Share in Volume by Region (2027-2032) Table 48. Global Adjuvants Sales by Region (2027-2032) & (US$ Million) Table 49. Global Adjuvants Sales Market Share in Value by Region (2027-2032) Table 50. Global Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Adjuvants Sales by Application (2021-2026) & (Tons) Table 53. Global Adjuvants Sales Market Share in Volume by Application (2021-2026) Table 54. Global Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 55. Global Adjuvants Sales Market Share in Value by Application (2021-2026) Table 56. Global Adjuvants Price by Application (2021-2026) & (US$/Kg) Table 57. Global Adjuvants Sales by Application (2027-2032) & (Tons) Table 58. Global Adjuvants Sales Market Share in Volume by Application (2027-2032) Table 59. Global Adjuvants Sales by Application (2027-2032) & (US$ Million) Table 60. Global Adjuvants Sales Market Share in Value by Application (2027-2032) Table 61. Global Adjuvants Price by Application (2027-2032) & (US$/Kg) Table 62. North America Adjuvants Sales by Application (2021-2026) & (Tons) Table 63. North America Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Adjuvants Sales by Application (2021-2026) & (Tons) Table 65. Europe Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Adjuvants Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Adjuvants Sales by Application (2021-2026) & (Tons) Table 69. Latin America Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Adjuvants Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. GSK Adjuvants Product Portfolio Table 76. GSK Recent Development Table 77. Croda Company Information Table 78. Croda Business Overview Table 79. Croda Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Croda Adjuvants Product Portfolio Table 81. Croda Recent Development Table 82. CSL Limited Company Information Table 83. CSL Limited Business Overview Table 84. CSL Limited Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. CSL Limited Adjuvants Product Portfolio Table 86. CSL Limited Recent Development Table 87. Phibro Animal Health Company Information Table 88. Phibro Animal Health Business Overview Table 89. Phibro Animal Health Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Phibro Animal Health Adjuvants Product Portfolio Table 91. Phibro Animal Health Recent Development Table 92. SDA BIO Company Information Table 93. SDA BIO Business Overview Table 94. SDA BIO Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. SDA BIO Adjuvants Product Portfolio Table 96. SDA BIO Recent Development Table 97. SEPPIC Company Information Table 98. SEPPIC Business Overview Table 99. SEPPIC Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. SEPPIC Adjuvants Product Portfolio Table 101. SEPPIC Recent Development Table 102. SPI Pharma Company Information Table 103. SPI Pharma Business Overview Table 104. SPI Pharma Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. SPI Pharma Adjuvants Product Portfolio Table 106. SPI Pharma Recent Development Table 107. Vertellus Company Information Table 108. Vertellus Business Overview Table 109. Vertellus Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Vertellus Adjuvants Product Portfolio Table 111. Vertellus Recent Development Table 112. Huanuotai Biological Company Information Table 113. Huanuotai Biological Business Overview Table 114. Huanuotai Biological Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Huanuotai Biological Adjuvants Product Portfolio Table 116. Huanuotai Biological Recent Development Table 117. Rico Bio Company Information Table 118. Rico Bio Business Overview Table 119. Rico Bio Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Rico Bio Adjuvants Product Portfolio Table 121. Rico Bio Recent Development Table 122. Sanofi Company Information Table 123. Sanofi Business Overview Table 124. Sanofi Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Sanofi Adjuvants Product Portfolio Table 126. Sanofi Recent Development Table 127. Escon Company Information Table 128. Escon Business Overview Table 129. Escon Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Escon Adjuvants Product Portfolio Table 131. Escon Recent Development Table 132. Zhifei Biological Company Information Table 133. Zhifei Biological Business Overview Table 134. Zhifei Biological Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Zhifei Biological Adjuvants Product Portfolio Table 136. Zhifei Biological Recent Development Table 137. North America Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. North America Adjuvants Sales by Country (2021-2026) & (Tons) Table 139. North America Adjuvants Sales Market Share by Country (2021-2026) Table 140. North America Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 141. North America Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 142. North America Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Adjuvants Market Share by Country (2021-2026) Table 145. North America Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Adjuvants Market Share Forecast by Country (2027-2032) Table 147. Europe Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Europe Adjuvants Sales by Country (2021-2026) & (Tons) Table 149. Europe Adjuvants Sales Market Share by Country (2021-2026) Table 150. Europe Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 151. Europe Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Adjuvants Market Share by Country (2021-2026) Table 155. Europe Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Adjuvants Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Adjuvants Sales by Country (2021-2026) & (Tons) Table 159. Asia-Pacific Adjuvants Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 161. Asia-Pacific Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Adjuvants Market Share by Country (2021-2026) Table 165. Asia-Pacific Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Adjuvants Market Share Forecast by Country (2027-2032) Table 167. Latin America Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 168. Latin America Adjuvants Sales by Country (2021-2026) & (Tons) Table 169. Latin America Adjuvants Sales Market Share by Country (2021-2026) Table 170. Latin America Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 171. Latin America Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Adjuvants Market Share by Country (2021-2026) Table 175. Latin America Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Adjuvants Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Adjuvants Sales by Country (2021-2026) & (Tons) Table 179. Middle East and Africa Adjuvants Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 181. Middle East and Africa Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Adjuvants Market Share by Country (2021-2026) Table 185. Middle East and Africa Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Adjuvants Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Adjuvants Distributors List Table 190. Adjuvants Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Adjuvants Image Figure 2. Global Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Adjuvants Sales (2021-2032) & (Tons) Figure 5. Emulsion Adjuvants Image Figure 6. Global Emulsion Adjuvants Sales YoY Growth (2021-2032) & (Tons) Figure 7. Mineral Adjuvants Image Figure 8. Global Mineral Adjuvants Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Adjuvants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Adjuvants Market Share by Type 2025 VS 2032 Figure 13. North America Adjuvants Sales Market Share in Volume by Type in 2025 Figure 14. North America Adjuvants Sales Market Share in Value by Type in 2025 Figure 15. Europe Adjuvants Sales Market Share in Volume by Type in 2025 Figure 16. Europe Adjuvants Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Adjuvants Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Adjuvants Sales Market Share in Value by Type in 2025 Figure 19. Latin America Adjuvants Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Adjuvants Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Adjuvants Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Adjuvants Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Adjuvants Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Vaccine Image Figure 26. Global Human Vaccine Sales YoY Growth (2021-2032) & (Tons) Figure 27. Veterinary Vaccine Image Figure 28. Global Veterinary Vaccine Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Adjuvants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Adjuvants Market Share by Application 2025 VS 2032 Figure 31. North America Adjuvants Sales Market Share in Volume by Application in 2025 Figure 32. North America Adjuvants Sales Market Share in Value by Application in 2025 Figure 33. Europe Adjuvants Sales Market Share in Volume by Application in 2025 Figure 34. Europe Adjuvants Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Adjuvants Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Adjuvants Sales Market Share in Value by Application in 2025 Figure 37. Latin America Adjuvants Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Adjuvants Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Adjuvants Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Adjuvants Sales Market Share in Value by Application in 2025 Figure 41. North America Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Adjuvants Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Adjuvants Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Emulsion Adjuvants
  • Mineral Adjuvants
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • Croda
  • CSL Limited
  • Phibro Animal Health
  • SDA BIO
  • SEPPIC
  • SPI Pharma
  • Vertellus
  • Huanuotai Biological
  • Rico Bio
  • Sanofi
  • Escon
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Adjuvants Market by Type
  6. 1.3.1 Emulsion Adjuvants
  7. 1.3.2 Mineral Adjuvants
  8. 1.3.3 Others
  9. 1.4 Global Adjuvants Market Size by Type
  10. 1.4.1 Global Adjuvants Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Adjuvants Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Adjuvants Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Adjuvants Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Adjuvants Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Adjuvants Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Adjuvants Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Adjuvants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Adjuvants Industry Trends
  2. 2.2 Adjuvants Industry Drivers
  3. 2.3 Adjuvants Industry Opportunities and Challenges
  4. 2.4 Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Adjuvants Revenue (2021-2026)
  2. 3.2 Global Top Players by Adjuvants Sales (2021-2026)
  3. 3.3 Global Top Players by Adjuvants Price (2021-2026)
  4. 3.4 Global Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adjuvants Major Company Production Sites & Headquarters
  6. 3.6 Global Adjuvants Company, Product Type & Application
  7. 3.7 Global Adjuvants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adjuvants Tier 1, Tier 2, and Tier 3
4 Adjuvants Regional Status and Outlook
  1. 4.1 Global Adjuvants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Adjuvants Historic Market Size by Region
  3. 4.2.1 Global Adjuvants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Adjuvants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Adjuvants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Adjuvants Forecasted Market Size by Region
  7. 4.3.1 Global Adjuvants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Adjuvants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Adjuvants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Adjuvants by Application
  1. 5.1 Adjuvants Market by Application
  2. 5.1.1 Human Vaccine
  3. 5.1.2 Veterinary Vaccine
  4. 5.2 Global Adjuvants Market Size by Application
  5. 5.2.1 Global Adjuvants Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Adjuvants Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Adjuvants Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Adjuvants Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Adjuvants Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Adjuvants Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Adjuvants Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Adjuvants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Adjuvants Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Croda
  8. 6.2.1 Croda Company Information
  9. 6.2.2 Croda Business Overview
  10. 6.2.3 Croda Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Croda Adjuvants Product Portfolio
  12. 6.2.5 Croda Recent Developments
  13. 6.3 CSL Limited
  14. 6.3.1 CSL Limited Company Information
  15. 6.3.2 CSL Limited Business Overview
  16. 6.3.3 CSL Limited Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Limited Adjuvants Product Portfolio
  18. 6.3.5 CSL Limited Recent Developments
  19. 6.4 Phibro Animal Health
  20. 6.4.1 Phibro Animal Health Company Information
  21. 6.4.2 Phibro Animal Health Business Overview
  22. 6.4.3 Phibro Animal Health Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Phibro Animal Health Adjuvants Product Portfolio
  24. 6.4.5 Phibro Animal Health Recent Developments
  25. 6.5 SDA BIO
  26. 6.5.1 SDA BIO Company Information
  27. 6.5.2 SDA BIO Business Overview
  28. 6.5.3 SDA BIO Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SDA BIO Adjuvants Product Portfolio
  30. 6.5.5 SDA BIO Recent Developments
  31. 6.6 SEPPIC
  32. 6.6.1 SEPPIC Company Information
  33. 6.6.2 SEPPIC Business Overview
  34. 6.6.3 SEPPIC Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SEPPIC Adjuvants Product Portfolio
  36. 6.6.5 SEPPIC Recent Developments
  37. 6.7 SPI Pharma
  38. 6.7.1 SPI Pharma Company Information
  39. 6.7.2 SPI Pharma Business Overview
  40. 6.7.3 SPI Pharma Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SPI Pharma Adjuvants Product Portfolio
  42. 6.7.5 SPI Pharma Recent Developments
  43. 6.8 Vertellus
  44. 6.8.1 Vertellus Company Information
  45. 6.8.2 Vertellus Business Overview
  46. 6.8.3 Vertellus Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vertellus Adjuvants Product Portfolio
  48. 6.8.5 Vertellus Recent Developments
  49. 6.9 Huanuotai Biological
  50. 6.9.1 Huanuotai Biological Company Information
  51. 6.9.2 Huanuotai Biological Business Overview
  52. 6.9.3 Huanuotai Biological Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Huanuotai Biological Adjuvants Product Portfolio
  54. 6.9.5 Huanuotai Biological Recent Developments
  55. 6.10 Rico Bio
  56. 6.10.1 Rico Bio Company Information
  57. 6.10.2 Rico Bio Business Overview
  58. 6.10.3 Rico Bio Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Rico Bio Adjuvants Product Portfolio
  60. 6.10.5 Rico Bio Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Adjuvants Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Escon
  68. 6.12.1 Escon Company Information
  69. 6.12.2 Escon Business Overview
  70. 6.12.3 Escon Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Escon Adjuvants Product Portfolio
  72. 6.12.5 Escon Recent Developments
  73. 6.13 Zhifei Biological
  74. 6.13.1 Zhifei Biological Company Information
  75. 6.13.2 Zhifei Biological Business Overview
  76. 6.13.3 Zhifei Biological Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zhifei Biological Adjuvants Product Portfolio
  78. 6.13.5 Zhifei Biological Recent Developments
7 North America by Country
  1. 7.1 North America Adjuvants Sales by Country
  2. 7.1.1 North America Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Adjuvants Sales by Country (2021-2026)
  4. 7.1.3 North America Adjuvants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Adjuvants Market Size by Country
  6. 7.2.1 North America Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Adjuvants Market Size by Country (2021-2026)
  8. 7.2.3 North America Adjuvants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Adjuvants Sales by Country
  2. 8.1.1 Europe Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Adjuvants Sales by Country (2021-2026)
  4. 8.1.3 Europe Adjuvants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Adjuvants Market Size by Country
  6. 8.2.1 Europe Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Adjuvants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Adjuvants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Adjuvants Sales by Country
  2. 9.1.1 Asia-Pacific Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Adjuvants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Adjuvants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Adjuvants Market Size by Country
  6. 9.2.1 Asia-Pacific Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Adjuvants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Adjuvants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Adjuvants Sales by Country
  2. 10.1.1 South America Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Adjuvants Sales by Country (2021-2026)
  4. 10.1.3 South America Adjuvants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Adjuvants Market Size by Country
  6. 10.2.1 South America Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Adjuvants Market Size by Country (2021-2026)
  8. 10.2.3 South America Adjuvants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Adjuvants Sales by Country
  2. 11.1.1 Middle East and Africa Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Adjuvants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Adjuvants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Adjuvants Market Size by Country
  6. 11.2.1 Middle East and Africa Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Adjuvants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Adjuvants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Adjuvants Value Chain Analysis
  2. 12.1.1 Adjuvants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Adjuvants Production Mode & Process
  7. 12.2 Adjuvants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Adjuvants Distributors
  10. 12.2.3 Adjuvants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst